Myelodysplastic Syndrome

Overview

Myelodysplastic syndrome, often called MDS, is a group of disorders that affect the bone marrow. The bone marrow is the soft tissue inside bones where blood cells are made. In MDS, the bone marrow does not produce enough healthy blood cells. Some blood cells may be abnormal and may not mature properly, leading to low levels of red blood cells, white blood cells, and/or platelets.

MDS can vary widely from person to person. In some people, it progresses slowly and causes few symptoms for a long time. In others, it may be more active and require closer monitoring or treatment. In certain cases, MDS can develop into a more aggressive blood cancer. For this reason, evaluation by a hematology specialist is important.

Symptoms

Symptoms of myelodysplastic syndrome are usually related to low blood cell counts. Some people have no symptoms at first, and MDS is found during routine blood tests. When symptoms occur, they may include:

• Tiredness, weakness, or reduced ability to exercise
• Shortness of breath, especially with activity
• Pale skin, dizziness, or feeling lightheaded
• Frequent infections or infections that are slow to improve
• Easy bruising or bleeding
• Nosebleeds, bleeding gums, or small red or purple spots on the skin
• Unexplained fever or general feeling of being unwell

These symptoms can also occur with many other conditions. Having one or more of them does not mean a person has MDS, but persistent or unexplained symptoms should be assessed by a doctor.

Causes and Risk Factors

In many cases, the exact cause of myelodysplastic syndrome is not known. MDS happens when blood-forming cells in the bone marrow develop genetic changes that affect how they grow and mature. These changes are usually acquired during a person’s lifetime and are not commonly inherited from parents.

Risk factors that may increase the chance of developing MDS include:

• Older age, as MDS is more common in later adulthood
• Previous treatment with chemotherapy or radiation therapy
• Exposure to certain industrial chemicals or toxins
• Long-term exposure to high levels of radiation
• Certain inherited bone marrow failure conditions, which are uncommon

Having a risk factor does not mean a person will develop MDS, and some people with MDS have no clear risk factors.

Diagnosis

Diagnosis of myelodysplastic syndrome usually begins with a medical history, physical examination, and blood tests. A complete blood count can show whether red blood cells, white blood cells, or platelets are low. A blood smear may also be examined under a microscope to look at the size, shape, and maturity of blood cells.

If MDS is suspected, a bone marrow examination is often needed. This involves taking a small sample of bone marrow and bone marrow fluid, usually from the hip bone, to study the cells in detail. Laboratory tests may look for abnormal cell appearance, chromosome changes, or specific genetic changes. These results help doctors classify the type of MDS and estimate how active the disease may be.

Additional tests may be performed to rule out other causes of low blood counts, such as vitamin deficiencies, infections, immune conditions, or other bone marrow disorders. Because MDS is complex, diagnosis and classification are typically managed by a hematologist.

Treatment Options

Treatment for myelodysplastic syndrome depends on several factors, including the type of MDS, blood counts, symptoms, genetic findings, overall health, and the risk of progression. Some people with low-risk or symptom-free disease may be monitored with regular check-ups and blood tests before active treatment is needed.

Supportive care is an important part of MDS management. It may include blood transfusions to improve symptoms caused by low red blood cells or low platelets. In some cases, treatments may be used to help the bone marrow produce more blood cells. Doctors may also recommend measures to reduce infection risk or manage iron buildup that can occur after repeated transfusions.

For some patients, medicines that affect bone marrow cell growth or the immune system may be considered. In selected situations, chemotherapy-based treatment may be used, especially if the disease is more active or has features closer to acute leukemia. The most intensive treatment option is a stem cell transplant, which replaces diseased bone marrow with healthy blood-forming cells from a donor. This treatment is not suitable for everyone and depends on age, general health, donor availability, and disease characteristics.

The goal of treatment may be to improve blood counts, reduce symptoms, lower the need for transfusions, slow disease progression, or prepare for more intensive therapy. The most appropriate plan should be discussed individually with a hematology team.

When to See a Doctor

A doctor should be consulted if there is persistent fatigue, shortness of breath, frequent infections, unusual bruising, prolonged bleeding, or unexplained fever. Medical advice is also important if routine blood tests show low blood cell counts or abnormal blood results.

People already diagnosed with MDS should keep scheduled follow-up appointments and report new or worsening symptoms promptly. Urgent medical attention is needed for signs such as heavy bleeding, severe shortness of breath, chest pain, high fever, confusion, or rapidly worsening weakness.

Early evaluation helps identify the cause of symptoms and allows timely planning of appropriate care. A hematologist can explain test results, discuss monitoring, and recommend treatment options based on the individual situation.